Oust stock forecast based on recent option chain activity

Based on recent option chain activity, the Oust stock forecast hints at possible upward momentum, as call option open interest surged 25% over the past week. Ouster currently has an average brokerage recommendation (ABR) of 1.80, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by five brokerage firms. An ABR of 1.80 approximates between Strong Buy and Buy. Before you consider Eyepoint Pharmaceuticals, you'll want to hear this. Global supply chain improvements could strengthen the Oust stock forecast, potentially allowing the firm to reach its higher Q4 delivery targets.